je.st
news
Home
› Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals
Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals
2013-09-04 06:25:07| drugdiscoveryonline News Articles
Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced recently the US FDA acceptance of the IND filing for a novel molecule targeting prostate cancer with Endo Pharmaceuticals of the US
Tags: successful
drug
filing
announces
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||